PRO-Br inhibits HDAC6 activity and promotes HSP90 acetylation, thereby recruiting HSC70 for tau degradation via chaperone-mediated autophagy (CMA) in AD models (Figure 8C). Here, MAPT is linked to Alzheimer disease.